Numerous pathogenic mutations in the TARDBP gene (>50 mutations) have been identified in both sporadic and familial cases of ALS and FTLD-TDP, accounting for six percent of global familial ALS (FALS) patients. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.